Rutgers University Study of the Genetics of Pulmonary Hypertension

NCT07217522 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-11-03

No results posted yet for this study

Summary

The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.

Conditions

  • Pulmonary Hypertension
  • Pulmonary Arterial Hypertension
  • Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
  • Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
  • Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)
  • Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
  • Pulmonary Arterial Hypertension of Congenital Heart Disease
  • Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

Interventions

GENETIC

Saliva sample

Saliva sample is sent via prepaid US Mail for DNA extraction

OTHER

Health surveys

Health surveys are filled out online in the study portal.

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Tara Matise, Ph.D. · Rutgers, The State University of New Jersey

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-23
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07217522 on ClinicalTrials.gov